Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma
Completed · Phase 2/Phase 3
Conditions studied: Melanoma, Neoplasm Metastasis
In brief
Subjects are randomized to one of two treatment arms. All subjects are screened for eligibility within 28 days prior to randomization. The study consists of a treatment phase and a follow-up phase. Subjects will be treated in repeating 4 week cycles.
Key facts
- Study ID
- NCT00055562
- Run by
- Celgene Corporation
- People needed
- 274
- Starts
- 2003-01-01
- Expected to finish
- 2004-12-01
- Last updated by the study team
- 2005-06-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Arizona Cancer Center — Tucson, Arizona, United States
- University of Southern California Norris Cancer Center — Los Angeles, California, United States
- UCLA — Los Angeles, California, United States
- St. Francis Memorial Hospital — San Francisco, California, United States
- Outpatient Clinic — Santa Monica, California, United States
- University of Colorado — Aurora, Colorado, United States
- The Harold Lever Regional Cancer Center — Waterbury, Connecticut, United States
- Lakeland Regional Cancer Center — Lakeland, Florida, United States
- Mount Sinai Comprehensive Cancer Center — Miami Beach, Florida, United States
- Lutheran General — Park Ridge, Illinois, United States
- Carle Clinic — Urbana, Illinois, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Ctr — Boston, Massachusetts, United States
- Spectrum Health — Grand Rapids, Michigan, United States
- Ellis Fischel Cancer Center — Columbia, Missouri, United States
- Washington University School of Medicine — St Louis, Missouri, United States
- Melanoma Center of St Louis — St Louis, Missouri, United States
- Biomedical Research Alliance of New York — New York, New York, United States
- Memorial Sloan Kettering Cancer Center — New York, New York, United States
- The Linder Clinical Trial Center — Cincinnati, Ohio, United States
- Cleveland Clinic Foundation — Cleveland, Ohio, United States
- Penn State Hershey Medical Center — Hershey, Pennsylvania, United States
- UPMC Cancer Pavillion — Pittsburgh, Pennsylvania, United States
- Sarah Cannon Cancer Center — Nashville, Tennessee, United States
- MD Anderson Cancer Center — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.